Risk stratification of HPV-positive women in routine cervical screening

M. Cruickshank

doi:10.1111/1471-0528.16695

Risk stratification of HPV-positive women in routine cervical screening

M. Cruickshank^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Abstract

High‐risk HPV primary screening is replacing organised cytology‐based screening based on increased sensitivity to detect high‐grade intra‐epithelial neoplasia and the very high negative predictive value, which will allow extended screening intervals.

Original language	English
Pages (from-to)	1363
Number of pages	1
Journal	BJOG-An International Journal of Obstetrics and Gynaecology
Volume	128
Issue number	8
Early online date	8 Mar 2021
DOIs	https://doi.org/10.1111/1471-0528.16695
Publication status	Published - Jul 2021

Bibliographical note

[email protected]: Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK

Access to Document

10.1111/1471-0528.16695Licence: Unspecified

Cite this

@article{67da4183565c4de18b6a9487bc552811,

title = "Risk stratification of HPV-positive women in routine cervical screening",

abstract = "High‐risk HPV primary screening is replacing organised cytology‐based screening based on increased sensitivity to detect high‐grade intra‐epithelial neoplasia and the very high negative predictive value, which will allow extended screening intervals.",

author = "M. Cruickshank",

note = "[email protected]: Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK",

year = "2021",

month = jul,

doi = "10.1111/1471-0528.16695",

language = "English",

volume = "128",

pages = "1363",

journal = "BJOG-An International Journal of Obstetrics and Gynaecology",

issn = "1470-0328",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "8",

}

TY - JOUR

T1 - Risk stratification of HPV-positive women in routine cervical screening

AU - Cruickshank, M.

N1 - [email protected]: Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK

PY - 2021/7

Y1 - 2021/7

N2 - High‐risk HPV primary screening is replacing organised cytology‐based screening based on increased sensitivity to detect high‐grade intra‐epithelial neoplasia and the very high negative predictive value, which will allow extended screening intervals.

AB - High‐risk HPV primary screening is replacing organised cytology‐based screening based on increased sensitivity to detect high‐grade intra‐epithelial neoplasia and the very high negative predictive value, which will allow extended screening intervals.

U2 - 10.1111/1471-0528.16695

DO - 10.1111/1471-0528.16695

M3 - Comment/debate

SN - 1470-0328

VL - 128

SP - 1363

JO - BJOG-An International Journal of Obstetrics and Gynaecology

JF - BJOG-An International Journal of Obstetrics and Gynaecology

IS - 8

ER -

Risk stratification of HPV-positive women in routine cervical screening

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this